Lilian Alcaraz,Terry Aaron Panchal,Andrew Stephen Robert Jennings,Andrew Peter Cridland,Christopher Hurley
申请号：
US14895718
公开号：
US09573949B2
申请日:
2013.06.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Mitogen activated protein kinase (MAPK) inhibitors disclosed herein are useful for the treatment of diseases of the respiratory tract, such as chronic eosinophilic pneumonia, asthma, COPD, adult respiratory distress syndrome (ARDS), exacerbation of airways hyper-reactivity consequent to other drug therapy, and airways disease that is associated with pulmonary hypertension.
